Clinical Trial Update: An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of grazoprevir and elbasvir for treatment-naïve chronic hepatitis C patients on opiate substitution therapy; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Grazoprevir/Elbasvir

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2016-07-11